← All trials
NCT04600999
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 7, 2020
- Primary completion
- Jun 30, 2021
- Completion date
- Jun 30, 2021
- First posted
- Oct 23, 2020
- Last posted
- Oct 23, 2020
- Enrollment
- 150
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of PecsLead sponsor
- HECRIN ConsortiumCollaborator
- Government of HungaryCollaborator
- University of DebrecenOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.